Elevated sphingosine-1-phosphate promotes sickling and sickle cell disease progression

Yujin Zhang(The University of Texas Health Science Center at Houston), Yang Xia(Northcentral University), Jianping Jin(Shaoxing University), Vladimír Berka(The University of Texas Health Science Center at Houston), Martin K. Safo(Virginia Commonwealth University), Mikhail Bogdanov(The University of Texas Health Science Center), Ah‐Lim Tsai(The University of Texas Health Science Center at Houston), Pumin Zhang(Guangxi Medical University), Mostafa H. Ahmed(Virginia Commonwealth University), Osheiza Abdulmalik(Children's Hospital of Philadelphia), Gregory J. Kato(RED Consulting (Norway)), Chonghua Li(The University of Texas Health Science Center at Houston), Kaiqi Sun(The University of Texas Health Science Center at Houston), Anren Song(The University of Texas Health Science Center), Modupe Idowu(The University of Texas Health Science Center at Houston), Jun Zhang(Jiangsu University), Wenzheng Zhang(Affiliated Hospital of Hangzhou Normal University), Ning Chen(Lund University), Qibo Zhang(Metabolon (United States)), Danny C. Alexander(Metabolon (United States)), Michael V. Milburn(Research Triangle Park Foundation), Harinder S. Juneja(The University of Texas Health Science Center at Houston), Weiru Zhang(Central South University), William Dowhan(The University of Texas Health Science Center), Wei Wang(Guangxi University), Rodney E. Kellems(Baylor College of Medicine)
Journal of Clinical Investigation
May 15, 2014
Cited by 125


Related Papers